Humacyte, Inc. (HUMA) NASDAQ

1.13

-0.04(-3.42%)

Updated at January 12 04:00PM

Currency In USD

Valuation

Market Cap598.32M
Enterprise Value569.92M
P/E Ratio-9.23
PEG Ratio-0.19
Price/Sales Ratio18.42
Price/Book Ratio-37.82
Enterprise/Revenue19.6
Enterprise/EBITDA-29.37

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-2.21
Operating Margin-11.98

Management Effectiveness

Return On Assets-0.21
Return On Equity4.49

Income Statement

Revenue0
Revenue/Share0.06
Gross Profit-7.19M
EBITDA-132.23M
Net Income-148.7M
Diluted EPS-1.26

Balance Sheet

Total Cash19.49M
Total Cash/Share0.12
Total Debt29.83M
Total Debt/Equity-6.28
Current Ratio1.62
Book Value Per Share-0.03

Price History

52-Week Change-74.15
52-Week High4.85
52-Week Low0.91
Moving Average 50 Days1.24
Moving Average 200 Days1.75

Statistics

Average Volume4.94M
Shares Outstanding142.82M
% Held by Institutions29.51

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A